DavidJFitzgeraldDOFACP, FCCP

Pulmonology • Albuquerque, NM

Critical Care Medicine, Pleural Disease

Board Certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine

Join to view full profile

Dr. Fitzgerald is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fitzgerald's full profile

Already have an account?

Office
8300 Constitution Avenue NE
Albuquerque, NM 87110
Phone+1 505-291-2100

Fax+1 505-291-2102

Education & Training

Medical College of GeorgiaFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1996
University of Kansas (Wichita)Residency, Internal Medicine, 1989 - 1993
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 1989

Certifications & Licensure

NM State License 2016 - 2027
CO State License 2007 - 2025
WY State License 2017 - 2025
DE State License 2017 - 2023
KS State License 1990 - 2022
ND State License 2015 - 2021
OK State License 2003 - 2008
GA State License 1993 - 2005
SC State License 1996 - 1996
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013

Publications & Presentations

PubMed

43 citations
Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers
Nathan Simon, David J. FitzGerald
Toxins. 2016-05-04
22 citations
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity
Matteo Pasetto, Antonella Antignani, Pinar Ormanoglu, Eugen Buehler, Rajarshi Guha
Proceedings of the National Academy of Sciences of the United States of America. 2015-03-10
14 citations
ABT-737 promotes the dislocation of ER luminal proteins to the cytosol, including Pseudomonas exotoxin.
Antonella Antignani, Robert Sarnovsky, David J. FitzGerald
Molecular Cancer Therapeutics. 2014-04-16

Grant Support

Bio-Therapies For The Treatment Of Cancer And Infectious DiseaseNational Cancer Institute2010–2011
Bio-Therapies For The Treatment Of Cancer And Infectious DiseaseDivision Of Basic Sciences - Nci2009
Bio-Therapies For The Treatment Of Cancer And Infectious DiseaseNational Cancer Institute2007–2008
Bio-Therapies For The Treatment Of Cancer And InfectiousDivision Of Basic Sciences - Nci2002–2006
Bio-Therapies For The Treatment Of Cancer And InfectionsDivision Of Basic Sciences - Nci2004
Bio-Therapies For Cancer And Infectious DiseaseDivision Of Basic Sciences - Nci2001
Bio-Therapies For The Treatment Of Cancer And Infectious DiseaseDivision Of Basic Sciences - Nci2000
Bio-Therapies For The Treatment Of Cancer And AIDSDivision Of Basic Sciences - Nci1999
Targeted Therapies For Treatment Of Cancer And AIDSDivision Of Basic Sciences - Nci1997–1998